ESG

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

A new patent embeds authenticity directly into semiconductor chips, moving beyond blockchain hype to offer a hardware guarantee against forgery for art and beyond.

NativState's purchase of a 50-year-old forestry firm isn't just M&A; it's a bet on carbon credits as the future for small Southern landowners.

As AI agents act with growing autonomy inside business tools, a new solution from MSPAlliance offers unprecedented visibility, shifting risk from a guess to a science.

As Canadian engineering giant Englobe reports explosive growth, its new sustainability report claims ESG is at its core. But can a company truly scale with purpose?

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

Lotus Tech's new sustainability report isn't just about green goals; it's a strategic play for investor trust with zero recalls and ambitious carbon targets.

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

A2MAC1's Tset acquisition is set to redefine automotive cost management, blending deep data with AI simulation to create a dynamic decision-making engine.

Bitget's listing of Bluwhale AI isn't just another token. It's a test case for AI-driven credit in Web3 and a key move in the exchange's ambitious strategy.

A new study reveals Canadians will pay $94.4 billion in debt interest this year, diverting funds from healthcare, education, and future growth.

As the Takaful market booms, leaders gather in London to tackle a new frontier: integrating climate risk and ESG into the core of ethical insurance.

Global e-commerce furniture brand Homary is opening a massive flagship in Paris. It's a high-stakes move into a crowded market and a critical test for the future of retail.

Slovenia's latest MICHELIN awards are more than a celebration; they reveal a national strategy of turning plates into policy and chefs into ambassadors.

After a 20-year drought, positive Phase 3 data for oral olorofim signals a safer, potent new option against a deadly fungus, promising a major market shake-up.

URBANICA’s new Conference Chair isn't just furniture; it's a calculated move into the office's most neglected real estate—the collaborative space.

Redress’s successful clothing drive is a testament to community action, but it starkly highlights the scale of Hong Kong's fast fashion and textile waste problem.

With plans to nearly double its store count, Five Below's new C-suite hires signal a calculated move to build an enduring retail empire, not just a brand.

GSK and Spero Therapeutics have won FDA approval for Utebzi, the first oral carbapenem for complex UTIs, a move that could slash healthcare costs.